Table 1.
Supplemental information about data provided for radiomics challenges.
| Data element | Description |
|---|---|
| Patient ID | Numbers given randomly to the patient after anonymization of the DICOM protected health identifier (PHI) tag (0010,0020) that corresponds to medical record number |
| HPV/p16 status | HPV status, as assessed by HPV DNA in situ hybridization (57) and/or p16 protein expression via immunohistochemistry, with the results described as 1 (i.e., positive) or 0 (i.e., negative) |
| Gender | Patient's sex |
| Age at diagnosis | Patient's age in years at the time of diagnosis |
| Race | American Indian/Alaska Native, Asian, Black, Hispanic, White, or not applicable |
| Tumor laterality | Right, left, or bilateral |
| Oropharynx subsite of origin | Subsite of the tumor within the oropharynx, i.e., base of tongue (21) or tonsil/soft palate/pharyngeal wall/glossopharyngeal sulcus/other (no single subsite of origin could be identified) |
| T category | Description of the original (primary) tumor with regard to size and extent per the American Joint Committee on Cancer (AJCC) and Union for International Cancer Control (UICC) cancer staging system, i.e., T1, T2, T3, or T4 (https://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging.aspx) |
| N category | Description of whether the cancer has reached nearby lymph nodes, per the AJCC and UICC cancer staging system, i.e., N0, N1, N2a, N2b, N2c, or N3 (https://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging.aspx) |
| AJCC stage | AJCC cancer stage (https://cancerstaging.org/references-tools/Pages/What-is-Cancer-Staging.aspx) |
| Pathologic grade | Grade of tumor differentiation, i.e., I, II, III, IV, I-II, II-III, or not assessable |
| Smoking status at diagnosis | Never, current, or former smoker |
| Smoking pack-years | An equivalent numerical value of lifetime tobacco exposure; 1 pack-year is defined as 20 cigarettes smoked every day for 1 year |